Cervical Cancer Trial Results
Long-Term Data Support Cisplatin-Based Chemoradiation for Cervical Cancer
(Posted: 05/29/2007) - Women with cervical cancer that had spread locally or regionally who received the chemotherapy drug cisplatin in addition to radiation therapy lived significantly longer than women who received a different kind of chemoradiation, according to the July 1, 2007, Journal of Clinical Oncology.
New Data from HPV Vaccine Trials Available
(Posted: 05/22/2007) - Results from three years of follow-up data from two clinical trials of Gardasil, a vaccine that protects against the HPV viruses known to cause 70 percent of all cases of cervical cancer, have been published in the May 10, 2007, New England Journal of Medicine.
(Posted: 05/29/2007) - Women with cervical cancer that had spread locally or regionally who received the chemotherapy drug cisplatin in addition to radiation therapy lived significantly longer than women who received a different kind of chemoradiation, according to the July 1, 2007, Journal of Clinical Oncology.
New Data from HPV Vaccine Trials Available
(Posted: 05/22/2007) - Results from three years of follow-up data from two clinical trials of Gardasil, a vaccine that protects against the HPV viruses known to cause 70 percent of all cases of cervical cancer, have been published in the May 10, 2007, New England Journal of Medicine.
